CE Mark for implantable RFID tag extended

Image source: Hologic

Long-term placement in breast lesions

CE Mark for implantable RFID tag extended

Hologic announced the extension of the CE Mark for its LOCalizer radiofrequency identification (RFID) tag for long-term placement.

The tag can now be implanted more than 30 days prior to a breast-conserving surgery, providing even greater flexibility and convenience to patients and providers. 

The LOCalizer wire-free guidance system is a non-radioactive, radiofrequency localization system designed for precise marking and targeting of lesions in breast-conserving surgery. It was designed to replace the traditional wire-guided localization method, which requires placement of a wire on the day of surgery. With this new tag, placement can be done weeks or months prior to surgery. For patients, this means they can arrive closer to their surgery time and experience fewer interventional procedures.

Following its earlier placement, the miniature implantable tag can be detected on the day of surgery by a portable, handheld reader that indicates the location and distance in mm to the lesion, enabling the surgeon to pinpoint the correct area of breast tissue for removal. Each tag also features a unique identification number that is displayed on the reader. This improved workflow is designed to help reduce scheduling and logistical hurdles for care teams, and aims to deliver added convenience for an enhanced patient experience.

“The extension of LOCalizer’s CE Mark is yet another reflection of our commitment to continue to seek innovative solutions that create a more positive experience for both patients and physicians,” said Jan Verstreken, Hologic's Regional President, EMEA, Canada & LatAm. “It also represents another way we are working to improve breast health throughout the entire patient journey, including for complex breast conserving surgeries.”

01.12.2019

More on the subject:More on companies:
Read all latest stories

Related articles

Photo

Sponsored • Lab diagnostics

Molecular scalable solutions for laboratories of every size

One size does not fit all when it comes to diagnostics. Different diagnostic locations need solutions that meet their needs, whether for on-demand testing in a healthcare setting or a laboratory…

Photo

Sponsored • Breast imaging congress

EUSOBI 2021: A turning point in women’s health

The breast imaging field plays a critical role in women’s health and wellbeing around the globe. Bringing together experts, leaders and innovators from across the breast imaging landscape, the 2021…

Photo

Sponsored • Breast cancer backlog

Getting cancer screening programmes back on track with AI and digitisation

The Covid-19 pandemic continues to impact people’s health across the world. This goes beyond the disease itself, as healthcare systems adapt how they provide services. Routine screening has been…

Related products

Hologic – 3Dimensions

Tomosynthesis

Hologic – 3Dimensions

Hologic, Inc.
Hologic -3DQuorum

Artificial Intelligence

Hologic -3DQuorum

Hologic, Inc.
Subscribe to Newsletter